联合应用肌酐与尿量分期优化改善全球肾脏病预后组织的急性肾损伤定义并识别住院患者死亡风险增加
这项前瞻性多中心国际队列纳入3429例连续入住ICU的儿童和年轻成人,来自Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study。研究将改善全球肾脏病预后组织的肌酐与尿量急性肾损伤标准序贯应用并相加,生成1–6分的AKI评分,主要终点为28天死亡。结果显示AKI评分1–3分死亡率与无急性肾损伤相似,而4–6分与死亡率增加相关;评分1–6分较无急性肾损伤更少在28天内转出ICU,评分2–6分较评分1分非恢复风险更高。在传统3期急性肾损伤队列内,评分4–6分较评分3分死亡率增加,评分5–6分ICU转出时间延长,评分6分非恢复率更高。
要点
- AKI评分由肌酐与尿量分期相加生成,范围1–6分,同时反映肾排泄与液体稳态功能障碍。
- AKI评分1–3分28天死亡率与无急性肾损伤相似,评分4–6分与死亡率增加相关。
- 相对无急性肾损伤,AKI评分1–6分均更少在28天内转出ICU。
- 相对AKI评分1分,评分2–6分非恢复风险更高。
- 在传统3期急性肾损伤内,评分4–6分较评分3分死亡率增加,评分5–6分ICU转出时间延长,评分6分非恢复率更高。
适用人群与场景
- 连续入住ICU的儿童和年轻成人,共3429例,来自Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study的多中心国际ICU协作。
诊断标准与关键阈值
- 将改善全球肾脏病预后组织的肌酐与尿量急性肾损伤标准序贯应用,两期相加生成1–6分的AKI评分。
研究设计与关键结果
- 前瞻性队列研究,纳入3429例连续入住ICU的儿童和年轻成人,来自多中心国际ICU协作。
- 主要终点28天死亡率:AKI评分1–3分与无急性肾损伤相似,AKI评分4–6分与死亡率增加相关。
- 次要终点:相对无急性肾损伤,AKI评分1–6分更少在28天内转出ICU;相对AKI评分1分,评分2–6分非恢复风险更高。
- 在传统改善全球肾脏病预后组织3期急性肾损伤队列内,较AKI评分3分,评分4–6分死亡率增加,评分5–6分ICU转出时间延长,评分6分非恢复率更高。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,联合应用肌酐与尿量标准可同时刻画肾排泄与液体稳态功能障碍,该AKI评分比传统分期方法更全面地描述严重急性肾损伤的结局意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Acute kidney injury is diagnosed according to creatinine and urine output criteria. Traditionally, both are applied, and a severity stage (1-3) is conferred based upon the more severe of the two; information from the other criteria is discarded. Physiologically, however, rising creatinine and oliguria represent two distinct types of renal dysfunction. We hypothesized that using the information from both criteria would more accurately characterize acute kidney injury severity and outcomes.
DESIGN: Prospective cohort study.
SETTING: Multicenter, international collaborative of ICUs.
PATIENTS: Three thousand four hundred twenty-nine children and young adults admitted consecutively to ICUs as part of the Assessment of the Worldwide Acute Kidney Injury, Renal Angina and Epidemiology Study.
MEASUREMENTS AND MAIN RESULTS: The Kidney Disease: Improving Global Outcomes creatinine and urine output acute kidney injury criteria were applied sequentially, and the two stages were summed, generating an Acute Kidney Injury (AKI) Score ranging from 1 to 6. The primary outcome was 28-day mortality; secondary outcomes were time until ICU discharge and nonrecovery from acute kidney injury. Models considered associations with AKI Score, assessing the relationship unadjusted and adjusted for covariates. Twenty-eight-day mortality and nonrecovery from acute kidney injury were modeled using logistic regression. For 28-day ICU discharge, competing risks analysis was performed. Although AKI Scores 1-3 had similar mortality to no Acute Kidney Injury, AKI Scores 4-6 were associated with increased mortality. Relative to No Acute Kidney Injury, AKI Scores 1-6 were less likely to be discharged from the ICU within 28 days. Relative to AKI Score 1, AKI Scores 2-6 were associated with higher risk of nonrecovery. Within the traditional Kidney Disease: Improving Global Outcomes Stage 3 acute kidney injury cohort, when compared with AKI Score 3, AKI Scores 4-6 had increased mortality, AKI Scores 5-6 had prolonged time to ICU discharge, and AKI Score 6 experienced higher nonrecovery rates.
CONCLUSIONS: Cumulative application of the creatinine and urine output criteria characterizes renal excretory and fluid homeostatic dysfunction simultaneously. This Acute Kidney Injury score more comprehensively describes the outcome implications of severe acute kidney injury than traditional staging methods.
参考来源
- Sutherland SM, Kaddourah A, Gillespie SE, et al. Cumulative Application of Creatinine and Urine Output Staging Optimizes the Kidney Disease: Improving Global Outcomes Definition and Identifies Increased Mortality Risk in Hospitalized Patients With Acute Kidney Injury. Crit Care Med. 2021. PMID: 33938717. doi:10.1097/CCM.0000000000005073
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。